Meningococcal Meningitis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2025-10-14
EMA Authorised: Menveo (meningococcal group A, C, W-135 and Y conjugate vaccine) — GSK Vaccines S.r.l.
EMA authorised Menveo, a meningococcal group A, C, W-135 and Y conjugate vaccine, for immunization against meningococcal disease. The decisi…